Your search returned 12 results.

Results
	1.	Is an observation period necessary after intravenous antibiotics are changed to oral administration? [electronic resource] by Beumont, M Schuster, M G Producer: 19990517 In: The American journal of medicine vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Quality of life in dermatology. [electronic resource] by Halioua, B Beumont, M G Lunel, F Producer: 20010125 In: International journal of dermatology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Mechanistic understanding of the nonlinear pharmacokinetics and intersubject variability of simeprevir: A PBPK-guided drug development approach. [electronic resource] by Snoeys, J Beumont, M Monshouwer, M Ouwerkerk-Mahadevan, S Producer: 20160525 In: Clinical pharmacology and therapeutics vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. [electronic resource] by Beumont, M G Graziani, A Ubel, P A MacGregor, R R Producer: 19960809 In: The American journal of medicine vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. [electronic resource] by Keiper, M D Beumont, M Elshami, A Langlotz, C P Miller, W T Producer: 19950207 In: Chest vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Veillonella myositis in an immunocompromised patient. [electronic resource] by Beumont, M G Duncan, J Mitchell, S D Esterhai, J L Edelstein, P H Producer: 19960201 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies. [electronic resource] by Scott, J Gilles, L Fu, M Brohan, E Panter, C Arbuckle, R Jessner, W Beumont, M Producer: 20160322 In: Journal of viral hepatitis vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. [electronic resource] by Zhang, H Dornadula, G Beumont, M Livornese, L Van Uitert, B Henning, K Pomerantz, R J Producer: 19981218 In: The New England journal of medicine vol. 339 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. [electronic resource] by Monsonego, J Pintos, J Semaille, C Beumont, M Dachez, R Zerat, L Bianchi, A Franco, E Producer: 20061012 In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes. [electronic resource] by De Meyer, S Ghys, A Foster, G R Beumont, M Van Baelen, B Lin, T-I Dierynck, I Ceulemans, H Picchio, G Producer: 20131129 In: Journal of viral hepatitis vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease. [electronic resource] by Lawitz, E Poordad, F Gutierrez, J A Kakuda, T N Picchio, G Beets, G Vandevoorde, A Van Remoortere, P Jacquemyn, B Luo, D Ouwerkerk-Mahadevan, S Vijgen, L Van Eygen, V Beumont, M Producer: 20171101 In: Journal of viral hepatitis vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection. [electronic resource] by Sulkowski, M S Feld, J J Lawitz, E Felizarta, F Corregidor, A M Khalid, O Ghalib, R Smith, W B Van Eygen, V Luo, D Vijgen, L Gamil, M Kakuda, T N Ouwerkerk-Mahadevan, S Van Remoortere, P Beumont, M Producer: 20181015 In: Journal of viral hepatitis vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)